Adage Capital Management, L.P.

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

170

Stocks Covered

Latest Filing

Feb 12, 2026

Filings

VINP

Vinci Partners Investments Ltd.

SC 13G/A · Nov 12, 2024

0.0%

0 shares

EYPT

EyePoint Pharmaceuticals, Inc.

SC 13G/A · Nov 12, 2024

7.1%

3.8M shares

SLNO

Soleno Therapeutics, Inc.

SC 13G/A · Nov 12, 2024

8.6%

3.3M shares

AURA

Aura Biosciences, Inc.

SC 13G/A · Nov 12, 2024

9.8%

4.9M shares

TENX

Tenax Therapeutics, Inc.

SC 13G · Nov 12, 2024

10.0%

369K shares

HRTX

Heron Therapeutics, Inc.

SC 13G · Nov 12, 2024

5.8%

8.8M shares

IMUX

Immunic, Inc.

SC 13G · Nov 12, 2024

6.2%

5.6M shares

MTEM

Molecular Templates, Inc.

SC 13G/A · Nov 12, 2024

0.0%

0 shares

ALGS

Aligos Therapeutics, Inc.

SC 13G · Nov 12, 2024

7.1%

219K shares

KALV

KalVista Pharmaceuticals, Inc.

SC 13G/A · Nov 12, 2024

3.3%

1.4M shares

LXEO

Lexeo Therapeutics, Inc.

SC 13G · Nov 12, 2024

7.9%

2.6M shares

URGN

UroGen Pharma Ltd.

SC 13G · Nov 12, 2024

8.9%

3.7M shares

SLDB

Solid Biosciences Inc.

SC 13G/A · Nov 12, 2024

4.5%

1.8M shares

ENGN

enGene Holdings Inc.

SC 13G · Nov 12, 2024

5.3%

2.3M shares

GLYC

GlycoMimetics, Inc.

SC 13D · Nov 4, 2024

7.9%

5.1M shares

ORKA

Oruka Therapeutics, Inc. (formerly known as ARCA biopharma, Inc.)

SC 13D/A · Oct 22, 2024

0.5%

175K shares

ABEO

Abeona Therapeutics Inc.

SC 13G/A · Jun 3, 2024

10.0%

4.2M shares

EYPT

EyePoint Pharmaceuticals, Inc.

SC 13G/A · May 1, 2024

9.9%

5.2M shares

EYPT

EyePoint Pharmaceuticals, Inc.

SC 13G · May 1, 2024

10.3%

5.2M shares

ABIO

ARCA biopharma, Inc.

SC 13D · Apr 5, 2024

8.3%

1.2M shares